Narwhal Capital Management Reduces Holdings in UnitedHealth Group Incorporated $UNH

Narwhal Capital Management decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 42.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 14,113 shares of the healthcare conglomerate's stock after selling 10,380 shares during the quarter. Narwhal Capital Management's holdings in UnitedHealth Group were worth $4,403,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in the company. Net Worth Advisory Group grew its position in UnitedHealth Group by 0.6% in the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock worth $1,907,000 after purchasing an additional 21 shares during the last quarter. Bensler LLC grew its position in UnitedHealth Group by 0.3% in the 1st quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate's stock worth $3,637,000 after purchasing an additional 22 shares during the last quarter. Lakeridge Wealth Management LLC grew its position in UnitedHealth Group by 5.8% in the 1st quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate's stock worth $220,000 after purchasing an additional 23 shares during the last quarter. Nabity Jensen Investment Management Inc grew its position in UnitedHealth Group by 0.9% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate's stock worth $1,446,000 after purchasing an additional 24 shares during the last quarter. Finally, BigSur Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 0.5% in the first quarter. BigSur Wealth Management LLC now owns 4,743 shares of the healthcare conglomerate's stock valued at $2,484,000 after acquiring an additional 25 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Up 1.7%

NYSE UNH opened at $369.88 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $334.99 billion, a price-to-earnings ratio of 16.03, a PEG ratio of 2.35 and a beta of 0.47. The firm's 50 day moving average price is $313.51 and its two-hundred day moving average price is $352.54.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 earnings per share. The company's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. Cantor Fitzgerald reiterated an "overweight" rating and issued a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Baird R W cut shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. Oppenheimer cut their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Finally, Wells Fargo & Company increased their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an "overweight" rating in a research note on Tuesday. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of "Hold" and an average target price of $372.68.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.